Roche and AbbVie line up for quick approval for cancer drug venetoclax

Damian Garde

Partners and are speeding toward FDA with a treatment tabbed as a potential blockbuster, picking up a priority review for a blood therapy.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS